Mitchell E. Taub

2.0k total citations
51 papers, 1.4k citations indexed

About

Mitchell E. Taub is a scholar working on Oncology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mitchell E. Taub has authored 51 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 15 papers in Pharmacology and 13 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mitchell E. Taub's work include Drug Transport and Resistance Mechanisms (31 papers), Pharmacogenetics and Drug Metabolism (14 papers) and Pharmacological Effects and Toxicity Studies (12 papers). Mitchell E. Taub is often cited by papers focused on Drug Transport and Resistance Mechanisms (31 papers), Pharmacogenetics and Drug Metabolism (14 papers) and Pharmacological Effects and Toxicity Studies (12 papers). Mitchell E. Taub collaborates with scholars based in United States, Germany and Japan. Mitchell E. Taub's co-authors include Lalitha Podila, Sven Frøkjær, Maciej J. Zamek‐Gliszczynski, Thomas Ebner, Rucha Sane, Harma Ellens, Bente Steffansen, Naoki Ishiguro, Xiaoyan Chu and Donald Tweedie and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Cell Science and Journal of Controlled Release.

In The Last Decade

Mitchell E. Taub

47 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitchell E. Taub United States 19 908 464 390 354 139 51 1.4k
Kathleen M. Hillgren United States 18 823 0.9× 424 0.9× 327 0.8× 372 1.1× 116 0.8× 30 1.4k
Katherine S. Fenner United Kingdom 20 1.0k 1.1× 483 1.0× 619 1.6× 337 1.0× 158 1.1× 28 1.7k
Jurjen S. Lagas Netherlands 21 1.2k 1.3× 385 0.8× 374 1.0× 501 1.4× 113 0.8× 29 1.7k
Annick Seithel Germany 6 765 0.8× 371 0.8× 251 0.6× 214 0.6× 132 0.9× 7 1.1k
Gustav Ahlin Sweden 7 813 0.9× 389 0.8× 245 0.6× 265 0.7× 141 1.0× 8 1.1k
Joseph A. Ware United States 25 999 1.1× 359 0.8× 385 1.0× 814 2.3× 103 0.7× 70 2.2k
Yong–Hae Han United States 19 584 0.6× 307 0.7× 295 0.8× 378 1.1× 96 0.7× 39 1.3k
Cindy Q. Xia United States 20 777 0.9× 307 0.7× 281 0.7× 481 1.4× 106 0.8× 47 1.4k
Maria Karlgren Sweden 19 740 0.8× 299 0.6× 567 1.5× 438 1.2× 110 0.8× 31 1.4k
Kelly Bleasby United States 16 674 0.7× 349 0.8× 236 0.6× 240 0.7× 165 1.2× 21 1.1k

Countries citing papers authored by Mitchell E. Taub

Since Specialization
Citations

This map shows the geographic impact of Mitchell E. Taub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell E. Taub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell E. Taub more than expected).

Fields of papers citing papers by Mitchell E. Taub

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell E. Taub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell E. Taub. The network helps show where Mitchell E. Taub may publish in the future.

Co-authorship network of co-authors of Mitchell E. Taub

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell E. Taub. A scholar is included among the top collaborators of Mitchell E. Taub based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell E. Taub. Mitchell E. Taub is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taherali, Farhan, Mitchell E. Taub, Felipe Varum, Roberto Bravo, & Abdul W. Basit. (2025). Investigating accumulation of budesonide and tacrolimus in an ex vivo porcine oesophageal model: Translational potential for local application of drugs to treat eosinophilic oesophagitis. European Journal of Pharmaceutical Sciences. 209. 107086–107086.
2.
Xie, Yuan, et al.. (2025). Investigating the bidirectional interactions between senotherapeutic agents and human gut microbiota. European Journal of Pharmaceutical Sciences. 209. 107098–107098.
3.
4.
Taub, Mitchell E., et al.. (2025). Improved clearance predictions for aldehyde oxidase substrates using a novel triculture human hepatocyte model. Drug Metabolism and Disposition. 53(4). 100051–100051. 1 indexed citations
5.
6.
Chan, Tom S., et al.. (2023). Characterization of Divergent Metabolic Pathways in Elucidating an Unexpected, Slow-Forming, and Long Half-Life Major Metabolite of Iclepertin. Pharmaceutical Research. 40(8). 1901–1913. 4 indexed citations
7.
Phillips, Jonathan A., Mitchell E. Taub, Matthew S. Bogdanffy, et al.. (2022). Mode of action and human relevance assessment of male CD‐1 mouse renal adenocarcinoma associated with lifetime exposure to empagliflozin. Journal of Applied Toxicology. 42(10). 1570–1584. 5 indexed citations
8.
Wiebe, Sabrina, Thomas Gießmann, Kathrin Hohl, et al.. (2020). Validation of a Drug Transporter Probe Cocktail Using the Prototypical Inhibitors Rifampin, Probenecid, Verapamil, and Cimetidine. Clinical Pharmacokinetics. 59(12). 1627–1639. 45 indexed citations
9.
Chan, Tom S., et al.. (2020). Evaluation of Erythromycin as a Tool to Assess CYP3A Contribution of Low Clearance Compounds in a Long-Term Hepatocyte Culture. Drug Metabolism and Disposition. 48(8). 690–697. 11 indexed citations
10.
Horspool, Alexander M., et al.. (2020). Human Liver Microsomes Immobilized on Magnetizable Beads: A Novel Approach to Study In Vitro Drug Metabolism. Drug Metabolism and Disposition. 48(8). 645–654. 12 indexed citations
11.
Zeng, Xingzhong, et al.. (2018). N-Methylation of BI 187004 by Thiol S-Methyltransferase. Drug Metabolism and Disposition. 46(6). 770–778. 4 indexed citations
12.
Ebner, Thomas, Naoki Ishiguro, & Mitchell E. Taub. (2015). The Use of Transporter Probe Drug Cocktails for the Assessment of Transporter-Based Drug–Drug Interactions in a Clinical Setting—Proposal of a Four Component Transporter Cocktail. Journal of Pharmaceutical Sciences. 104(9). 3220–3228. 58 indexed citations
13.
Lee, Caroline A., Tasha K. Ritchie, Aleksandra Galetin, et al.. (2015). Breast Cancer Resistance Protein (ABCG2) in Clinical Pharmacokinetics and Drug Interactions: Practical Recommendations for Clinical Victim and Perpetrator Drug-Drug Interaction Study Design. Drug Metabolism and Disposition. 43(4). 490–509. 108 indexed citations
14.
Li, Yongmei, Jin Zhou, Diane Ramsden, et al.. (2013). Enzyme-Transporter Interplay in the Formation and Clearance of Abundant Metabolites of Faldaprevir Found in Excreta but not in Circulation. Drug Metabolism and Disposition. 42(3). 384–393. 25 indexed citations
15.
Hodge, Lucy S., Mitchell E. Taub, & T. S. Tracy. (2011). Effect of its deaminated metabolite, 2′,2′-difluorodeoxyuridine, on the transport and toxicity of gemcitabine in HeLa cells. Biochemical Pharmacology. 81(7). 950–956. 22 indexed citations
16.
Gorman, Eric M., et al.. (2008). Exploration of Intestinal Calcium Precipitation as a Barrier to Absorption at High Calcium Doses. Pharmaceutical Research. 25(12). 2760–2768. 9 indexed citations
17.
Taub, Mitchell E., et al.. (2005). FUNCTIONAL ASSESSMENT OF MULTIPLE P-GLYCOPROTEIN (P-GP) PROBE SUBSTRATES: INFLUENCE OF CELL LINE AND MODULATOR CONCENTRATION ON P-GP ACTIVITY. Drug Metabolism and Disposition. 33(11). 1679–1687. 103 indexed citations
18.
Taub, Mitchell E., et al.. (2002). Optimized conditions for MDCK permeability and turbidimetric solubility studies using compounds representative of BCS classes I–IV. European Journal of Pharmaceutical Sciences. 15(4). 331–340. 58 indexed citations
19.
Jakobsen, Palle, et al.. (2001). Application of enzymatically stable dipeptides for enhancement of intestinal permeability. Synthesis and In vitro evaluation of dipeptide-Coupled compounds. Bioorganic & Medicinal Chemistry. 9(10). 2625–2632. 13 indexed citations
20.
Wan, Jianqiang, et al.. (1992). Brefeldin A enhances receptor-mediated transcytosis of transferrin in filter-grown Madin-Darby canine kidney cells.. Journal of Biological Chemistry. 267(19). 13446–13450. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathleen M. Hillgren Breakdown of academic impact, for papers by Katherine S. Fenner Breakdown of academic impact, for papers by Jurjen S. Lagas Breakdown of academic impact, for papers by Annick Seithel Breakdown of academic impact, for papers by Gustav Ahlin Breakdown of academic impact, for papers by Joseph A. Ware Breakdown of academic impact, for papers by Yong–Hae Han Breakdown of academic impact, for papers by Cindy Q. Xia Breakdown of academic impact, for papers by Maria Karlgren Breakdown of academic impact, for papers by Kelly Bleasby
Rankless by CCL
2026